Remove Networking Remove Pharmaceutical Remove Reporting
article thumbnail

Appetite for hybrid working shows no sign of letting up at large firms

Workplace Insight

And in 2023, companies have been posting hybrid working related roles in record numbers, according to a new report from GlobalData.

article thumbnail

Power, Privilege & Controlling the Narrative: Vested Interests in ‘Mental Health’

Mad in America

Information produced by professional bodies and charitable groups also promotes this view and it is reported by the media as if it were established fact. Davies describes a comprehensive UK government report on the influence of the pharmaceutical industry the House of Commons Health Select Committee Report on the Pharmaceutical Industry.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Robert Whitaker Answers Reader Questions on Pharma Marketing and Psychiatric Drugs

Mad in America

For Part 2, we will be covering reader questions on pharmaceutical marketing and issues with psychiatric treatments including psychiatric drugs and electroconvulsive therapy. There was a report that their diagnostic categories were invalid and unreliable. Mad in America, by being able to report on what’s happening in the U.K.,

article thumbnail

Beyond Medicalization: Psychedelic Therapy and the Promise of Community-Based Healing

Mad in America

House Bill 25-1063 , approved in April 2025, represents one such effort, revealing the intersection of commercial interests, intellectual property concerns, and the pharmaceutical model’s influence on psychedelic policy. These grassroots efforts often emphasize reciprocity, accessibility, and genuine community engagement.

article thumbnail

Critical Psychiatry Textbook, Chapter 16: Is There Any Future for Psychiatry? (Part Six)

Mad in America

335 In 2000, they co-authored a report of a depression pill trial in New England Journal of Medicine where the authors had so many ties to drug companies that there wasn’t room for them in the print journal (they took up 1067 words). In 2012, the US Centers for Disease Control reported that 25% of Americans have a mental illness.

article thumbnail

What Are We Overlooking? Reviewing Current and Alternative Treatments for Psychosis

Mad in America

The rate of ‘non-responders’ to the drugs is generally reported to be around 30–35%. My interpretation would be that this is due not to placebo effects as such, but reflects that participants in a research trial should be; receiving appropriate attention in the form of supportive care from professionals, and any support network they may have.

article thumbnail

Is Madness an Evolved Signal? Justin Garson on Strategy Versus Dysfunction

Mad in America

Moore: And of course, it was an open door then for the pharmaceutical industry, wasn’t it, with their massive marketing dollars. And I think she’s right that medical psychiatry and the pharmaceutical companies needed a vision like that. MIA Reports are made possible by donations from MIA readers like you.